(MAC) Macerich - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5543821012

MAC: Retail, Real Estate, Regional, Malls, Centers

The Macerich Company (NYSE: MAC) is a prominent real estate investment trust specializing in retail properties, with ownership of 43 million square feet across 40 regional retail centers. These assets serve as central hubs for their communities, primarily located in high-density, economically robust areas such as California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, D.C. corridor. The company is recognized for its commitment to sustainability, achieving the #1 GRESB ranking for the North American retail sector for ten consecutive years. Its focus extends to environmental stewardship, social responsibility, and strong corporate governance practices.

From a technical standpoint, MACs stock is currently trading at $14.83 with a 20-day average volume of 2,425,148 shares. The stocks short-term trend, indicated by the SMA 20 at $14.95, suggests a slightly bearish trajectory. The SMA 50 at $16.85 and SMA 200 at $17.69 further confirm this trend, as the stock is trading below these key moving averages. The ATR of 0.86 reflects moderate volatility.

Fundamentally, MAC has a market capitalization of $3.87 billion, with a forward P/E of 500.00 and a P/B ratio of 1.34, indicating that the stock is trading at a premium to its book value. The P/S ratio of 4.30 suggests a higher valuation relative to its revenue. However, the negative RoE of -7.05 raises concerns about profitability and efficiency in generating returns for shareholders.

Over the next three months, MAC is expected to remain under pressure due to its position below the SMA 50 and SMA 200. The stock may face resistance at $16.85, with potential support at $14.00. The high forward P/E of 500.00 and negative RoE of -7.05 could deter investors, leading to a potential decline to $12.50. However, if the stock breaks above $16.85, it could test $18.00. The ATR of 0.86 suggests moderate volatility, with potential price swings of $0.86 on average.

Additional Sources for MAC Stock

MAC Stock Overview

Market Cap in USD 3,870m
Sector Real Estate
Industry REIT - Retail
GiC Sub-Industry Retail REITs
IPO / Inception 1994-03-09

MAC Stock Ratings

Growth Rating 60.6
Fundamental 4.12
Dividend Rating 55.1
Rel. Strength -14.3
Analysts 3.13/5
Fair Price Momentum 14.48 USD
Fair Price DCF 24.27 USD

MAC Dividends

Dividend Yield 12m 4.23%
Yield on Cost 5y 11.56%
Annual Growth 5y -9.98%
Payout Consistency 92.1%

MAC Growth Ratios

Growth Correlation 3m -90.7%
Growth Correlation 12m 50.3%
Growth Correlation 5y 60.8%
CAGR 5y 22.24%
CAGR/Max DD 5y 0.35
Sharpe Ratio 12m 1.53
Alpha -15.45
Beta 1.144
Volatility 39.64%
Current Volume 1439.5k
Average Volume 20d 2297.9k
What is the price of MAC stocks?
As of April 30, 2025, the stock is trading at USD 14.68 with a total of 1,439,450 shares traded.
Over the past week, the price has changed by +6.87%, over one month by -11.71%, over three months by -26.04% and over the past year by -1.95%.
Is Macerich a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Macerich is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 4.12 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MAC as of April 2025 is 14.48. This means that MAC is currently overvalued and has a potential downside of -1.36%.
Is MAC a buy, sell or hold?
Macerich has received a consensus analysts rating of 3.13. Therefor, it is recommend to hold MAC.
  • Strong Buy: 2
  • Buy: 1
  • Hold: 9
  • Sell: 3
  • Strong Sell: 0
What are the forecast for MAC stock price target?
According to ValueRays Forecast Model, MAC Macerich will be worth about 15.8 in April 2026. The stock is currently trading at 14.68. This means that the stock has a potential upside of +7.36%.
Issuer Forecast Upside
Wallstreet Target Price 19 29.6%
Analysts Target Price 19 29.6%
ValueRay Target Price 15.8 7.4%